9 research outputs found
Early Validation of High-Tech Start-ups by Using Big Data
Source at https://circulareconomy.europa.eu/platform/en/news-and-events/all-events/ispim-innovation-conference-2023.Majority of the start-ups fail in the early stage of the development due to lack of validation. This paper focuses on high-tech start-ups and investigates the use of data and/or big data at this stage. The study found that early-stage start-ups fail because they create products or services not needed in the market. Early validation through an agile approach can help these young companies to manoeuver through a turbulent external environment. The results show that big data or data can act as a support at this stage. However, there are various barriers that need to be addressed for successful data adoption. The paper proposes an early validation user guide (EVU) to overcome these barriers and make data adoption easier. The EVU can provide start-ups the tools to use big data or data as a support for early validation based on the market context of the start-ups
Divergent β-hairpins determine double-strand versus single-strand substrate recognition of human AlkB-homologues 2 and 3
Human AlkB homologues ABH2 and ABH3 repair 1-methyladenine and 3-methylcytosine in DNA/RNA by oxidative demethylation. The enzymes have similar overall folds and active sites, but are functionally divergent. ABH2 efficiently demethylates both single- and double-stranded (ds) DNA, whereas ABH3 has a strong preference for single-stranded DNA and RNA. We find that divergent F1 β-hairpins in proximity of the active sites of ABH2 and ABH3 are central for substrate specificities. Swapping F1 hairpins between the enzymes resulted in hybrid proteins resembling the donor proteins. Surprisingly, mutation of the intercalating residue F102 had little effect on activity, while the double mutant V101A/F102A was catalytically impaired. These residues form part of an important hydrophobic network only present in ABH2. In this functionally important network, F124 stacks with the flipped out base while L157 apparently functions as a buffer stop to position the lesion in the catalytic pocket for repair. F1 in ABH3 contains charged and polar residues preventing use of dsDNA substrate. Thus, E123 in ABH3 corresponds to F102 in ABH2 and the E123F-variant gained capacity to repair dsDNA with no loss in single strand repair capacity. In conclusion, divergent sequences outside of the active site determine substrate specificities of ABH2 and ABH3
Uracil–DNA glycosylases SMUG1 and UNG2 coordinate the initial steps of base excision repair by distinct mechanisms
DNA glycosylases UNG and SMUG1 excise uracil from DNA and belong to the same protein superfamily. Vertebrates contain both SMUG1 and UNG, but their distinct roles in base excision repair (BER) of deaminated cytosine (U:G) are still not fully defined. Here we have examined the ability of human SMUG1 and UNG2 (nuclear UNG) to initiate and coordinate repair of U:G mismatches. When expressed in Escherichia coli cells, human UNG2 initiates complete repair of deaminated cytosine, while SMUG1 inhibits cell proliferation. In vitro, we show that SMUG1 binds tightly to AP-sites and inhibits AP-site cleavage by AP-endonucleases. Furthermore, a specific motif important for the AP-site product binding has been identified. Mutations in this motif increase catalytic turnover due to reduced product binding. In contrast, the highly efficient UNG2 lacks product-binding capacity and stimulates AP-site cleavage by APE1, facilitating the two first steps in BER. In summary, this work reveals that SMUG1 and UNG2 coordinate the initial steps of BER by distinct mechanisms. UNG2 is apparently adapted to rapid and highly coordinated repair of uracil (U:G and U:A) in replicating DNA, while the less efficient SMUG1 may be more important in repair of deaminated cytosine (U:G) in non-replicating chromatin
Cell cycle-specific UNG2 phosphorylations regulate protein turnover, activity and association with RPA
Human UNG2 is a multifunctional glycosylase that removes uracil near replication forks and in non-replicating DNA, and is important for affinity maturation of antibodies in B cells. How these diverse functions are regulated remains obscure. Here, we report three new phosphoforms of the non-catalytic domain that confer distinct functional properties to UNG2. These are apparently generated by cyclin-dependent kinases through stepwise phosphorylation of S23, T60 and S64 in the cell cycle. Phosphorylation of S23 in late G1/early S confers increased association with replication protein A (RPA) and replicating chromatin and markedly increases the catalytic turnover of UNG2. Conversely, progressive phosphorylation of T60 and S64 throughout S phase mediates reduced binding to RPA and flag UNG2 for breakdown in G2 by forming a cyclin E/c-myc-like phosphodegron. The enhanced catalytic turnover of UNG2 p-S23 likely optimises the protein to excise uracil along with rapidly moving replication forks. Our findings may aid further studies of how UNG2 initiates mutagenic rather than repair processing of activation-induced deaminase-generated uracil at Ig loci in B cells
Structure-function analysis of human enzymes initiating nucleobase repair in DNA and RNA
In humans, there are four known glycosylases that initiate repair of uracils in DNA. These are UNG, TDG, SMUG1, and MBD4. It was proposed that the replication independent SMUG1 was the main enzyme initiating removal of deaminated cytosine, whereas UNG2 was responsible for replication associated repair of mis-incorporated dUTP (Nilsen et al., 2001). We aimed at elucidating the specific function of the two main human uracil-DNA glycosylases in vitro and in vivo to further clarify their distinct roles in repair of uracils in the genome (Paper I). In Paper II, we continued the in-depth analysis of the distinct roles of hUNG2 and hSMUG1. We wanted to investigate whether hUNG2 and hSMUG1 coordinated the subsequent step in BER differentially, to characterize active-site residues in hSMUG1, and to elucidate the role of the extended DNA minor-groove intercalating motif of hSMUG1 in binding of the complementary DNA strand
Substrate specificities of bacterial and human AlkB proteins
Methylating agents introduce cytotoxic 1-methyladenine (1-meA) and 3-methylcytosine (3-meC) residues into nucleic acids, and it was recently demonstrated that the Escherichia coli AlkB protein and two human homologues, hABH2 and hABH3, can remove these lesions from DNA by oxidative demethylation. Moreover, AlkB and hABH3 were also found to remove 1-meA and 3-meC from RNA, suggesting that cellular RNA repair can occur. We have here studied the preference of AlkB, hABH2 and hABH3 for single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA), and show that AlkB and hABH3 prefer ssDNA, while hABH2 prefers dsDNA. This was consistently observed with three different oligonucleotide substrates, implying that the specificity for single-stranded versus double-stranded DNA is sequence independent. The dsDNA preference of hABH2 was observed only in the presence of magnesium. The activity of the enzymes on single-stranded RNA (ssRNA), double-stranded RNA (dsRNA) and DNA/RNA hybrids was also investigated, and the results generally confirm the notion that while AlkB and hABH3 tend to prefer single-stranded nucleic acids, hABH2 is more active on double-stranded substrates. These results may contribute to identifying the main substrates of bacterial and human AlkB proteins in vivo
Human AlkB Homolog 1 Is a Mitochondrial Protein That Demethylates 3-Methylcytosine in DNA and RNA*
The Escherichia coli AlkB protein and human homologs hABH2 and
hABH3 are 2-oxoglutarate (2OG)/Fe(II)-dependent DNA/RNA demethylases that
repair 1-methyladenine and 3-methylcytosine residues. Surprisingly, hABH1,
which displays the strongest homology to AlkB, failed to show repair activity
in two independent studies. Here, we show that hABH1 is a mitochondrial
protein, as demonstrated using fluorescent fusion protein expression,
immunocytochemistry, and Western blot analysis. A fraction is apparently
nuclear and this fraction increases strongly if the fluorescent tag is placed
at the N-terminal end of the protein, thus interfering with mitochondrial
targeting. Molecular modeling of hABH1 based upon the sequence and known
structures of AlkB and hABH3 suggested an active site almost identical to
these enzymes. hABH1 decarboxylates 2OG in the absence of a prime substrate,
and the activity is stimulated by methylated nucleotides. Employing three
different methods we demonstrate that hABH1 demethylates 3-methylcytosine in
single-stranded DNA and RNA in vitro. Site-specific mutagenesis
confirmed that the putative Fe(II) and 2OG binding residues are essential for
activity. In conclusion, hABH1 is a functional mitochondrial AlkB homolog that
repairs 3-methylcytosine in single-stranded DNA and RNA
Human ABH3 structure and key residues for oxidative demethylation to reverse DNA/RNA damage
Methylating agents are ubiquitous in the environment, and central in cancer therapy. The 1-methyladenine and 3-methylcytosine lesions in DNA/RNA contribute to the cytotoxicity of such agents. These lesions are directly reversed by ABH3 (hABH3) in humans and AlkB in Escherichia coli. Here, we report the structure of the hABH3 catalytic core in complex with iron and 2-oxoglutarate (2OG) at 1.5 Å resolution and analyse key site-directed mutants. The hABH3 structure reveals the β-strand jelly-roll fold that coordinates a catalytically active iron centre by a conserved His(1)-X-Asp/Glu-X(n)-His(2) motif. This experimentally establishes hABH3 as a structural member of the Fe(II)/2OG-dependent dioxygenase superfamily, which couples substrate oxidation to conversion of 2OG into succinate and CO(2). A positively charged DNA/RNA binding groove indicates a distinct nucleic acid binding conformation different from that predicted in the AlkB structure with three nucleotides. These results uncover previously unassigned key catalytic residues, identify a flexible hairpin involved in nucleotide flipping and ss/ds-DNA discrimination, and reveal self-hydroxylation of an active site leucine that may protect against uncoupled generation of dangerous oxygen radicals